Evidence map›Paper›PMID 21965682›Full record

ArticleThe Journal of biological chemistry2011

Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus.

Jin-Kyoung Kim, Eunjung Lee, Soyoung Shin, Ki-Woong Jeong, Jee-Young Lee, Su-Young Bae, Soo-Hyun Kim, Juneyoung Lee, Seong Ryul Kim, Dong Gun Lee and 2 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. RETRACTED: Curcumin-InjectedMolecules (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jin-Kyoung KimDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701.
Eunjung LeeDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701.
Soyoung ShinDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701.
Ki-Woong JeongDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701.
Jee-Young LeeDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701.
Su-Young BaeLaboratory of Cytokine Immunology, Institute of Biomedical Science and Technology, College of Medicine, Konkuk University, Seoul 143-701.
Soo-Hyun KimLaboratory of Cytokine Immunology, Institute of Biomedical Science and Technology, College of Medicine, Konkuk University, Seoul 143-701.
Juneyoung LeeSchool of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 702-701.
Seong Ryul KimNational Academy of Agricultural Science, Rural Development Administration, Suwon 441-100, South Korea.
Dong Gun LeeSchool of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 702-701.
Jae-Sam HwangNational Academy of Agricultural Science, Rural Development Administration, Suwon 441-100, South Korea.
Yangmee KimDepartment of Bioscience and Biotechnology, BMIC, Konkuk University, Seoul 143-701. Electronic address: ymkim@konkuk.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papiliocin is a novel 37-residue cecropin-like peptide isolated recently from the swallowtail butterfly, Papilio xuthus. With the aim of identifying a potent antimicrobial peptide, we tested papiliocin in a variety of biological and biophysical assays, demonstrating that the peptide possesses very low cytotoxicity against mammalian cells and high bacterial cell selectivity, particularly against Gram-negative bacteria as well as high anti-inflammatory activity. Using LPS-stimulated macrophage RAW264.7 cells, we found that papiliocin exerted its anti-inflammatory activities by inhibiting nitric oxide (NO) production and secretion of tumor necrosis factor (TNF)-α and macrophage inflammatory protein (MIP)-2, producing effects comparable with those of the antimicrobial peptide LL-37. We also showed that the innate defense response mechanisms engaged by papiliocin involve Toll-like receptor pathways that culminate in the nuclear translocation of NF-κB. Fluorescent dye leakage experiments showed that papiliocin targets the bacterial cell membrane. To understand structure-activity relationships, we determined the three-dimensional structure of papiliocin in 300 mm dodecylphosphocholine micelles by NMR spectroscopy, showing that papiliocin has an α-helical structure from Lys(3) to Lys(21) and from Ala(25) to Val(36), linked by a hinge region. Interactions between the papiliocin and LPS studied using tryptophan blue-shift data, and saturation transfer difference-NMR experiments revealed that Trp(2) and Phe(5) at the N-terminal helix play an important role in attracting papiliocin to the cell membrane of Gram-negative bacteria. In conclusion, we have demonstrated that papiliocin is a potent peptide antibiotic with both anti-inflammatory and antibacterial activities, and we have laid the groundwork for future studies of its mechanism of action.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAntimicrobial Cationic PeptidesBacteriaButterfliesCell LineChemokine CXCL2HumansInsect ProteinsLipopolysaccharidesMacrophage ActivationMacrophagesMiceNF-kappa BNitric OxideProtein Structure, SecondaryAnti-Inflammatory Agents, Non-SteroidalAntimicrobial Cationic PeptidesChemokine CXCL2Cxcl2 protein, mouseInsect ProteinsLipopolysaccharidesNF-kappa BNitric Oxidepapiliocin protein, Papilio xuthusToll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID21965682
PMCPMC3308842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.